ATM anticorps (AA 2050-2717)
Aperçu rapide pour ATM anticorps (AA 2050-2717) (ABIN1732026)
Antigène
Voir toutes ATM AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 2050-2717
-
Specificité
- Reacts with human and mouse ATM.
-
Purification
- Purified
-
Immunogène
- Synthetic peptide representing a portion of the ATM encoded within exon 53 (aa 2050-2717)
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB(0.1 - 0.4 μg/mL) IP(10 - 20 μg/mg) -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Tris citrate/phosphate, pH 7-8
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2 - 8°C. Antibody is stable at 2 - 8°C for 1 year.
-
-
- ATM (Ataxia Telangiectasia Mutated (ATM))
-
Autre désignation
- ATM
-
Sujet
- Serine-protein kinase ATM Ataxia telangiectasia mutated, A-T mutated Gene name: ATM, AT1, ATA, ATC, ATD, ATE, ATDC, TEL1, TELO1
-
ID gène
- 472
-
UniProt
- Q13315
-
Pathways
- Signalisation p53, Apoptose, Réparation de l'ADN, Inositol Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus
Antigène
-